The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.
IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.
IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.
Presentations from the IMI Stakeholder Forum are now available online [3]
EU-AIMS is developing tools that will help us to boost our understanding of autism spectrum disorders, paving the way for new treatments
... more [4]DIRECT is identifying different subtypes of type 2 diabetes to determine the most appropriate treatments for them
... more [5]EMTRAIN officially launches on-course - with over 4 200 courses, it's Europe's most comprehensive biomedical R&D postgrad course portal
... more [6]IMI supports 40 projects with a combined budget of €1.2 billion covering drug safety & efficacy, knowledge management, and education &... more [7]
MIP-DILI is developing tests to help detect liver toxicity problems early in development, saving many patients from the trauma of liver failure
... more [8]EUPATI is developing educational resources that will empower patients to engage more effectively in the drug research and development process
... more [9]PreDiCT-TB is speeding up the search for new, more effective combinations of treatments to tackle the deadly disease tuberculosis (TB)
... more [10]ABIRISK is boosting the safety of biopharmaceuticals, novel drugs that have already proven effective at treating certain serious conditions.
... more [11]BIOVACSAFE is developing cutting edge tools to speed up and improve the testing and monitoring of vaccine safety
... more [12]Four of IMI's Education & Training projects have put together a short film presenting their work. Whether you're a student or a course provider, this video will tell you how IMI's projects can help you.
more [14]
Follow us on Twitter [15]
Links:
[1] http://ec.europa.eu/research/health/index_en.html
[2] http://www.efpia.org/
[3] http://www.imi.europa.eu/events/2013/03/01/imi-stakeholder-forum-2013
[4] http://www.imi.europa.eu/eu-aims
[5] http://www.imi.europa.eu/direct
[6] http://www.on-course.eu/
[7] http://www.imi.europa.eu/ongoing-projects
[8] http://www.imi.europa.eu/mip-dili
[9] http://www.imi.europa.eu/eupati
[10] http://www.imi.europa.eu/predict-tb
[11] http://www.imi.europa.eu/content/abirisk
[12] http://www.imi.europa.eu/biovacsafe
[13] http://www.imi.europa.eu/content/ongoing-projects
[14] http://www.youtube.com/watch?v=1uopWSVI6x0
[15] https://twitter.com/IMI_JU
[16] http://t.co/EYr3Ik6qu1
[17] http://www.imi.europa.eu/content/subscribe-imi-newsletter
[18] http://www.imi.europa.eu/events/2013/05/06/financial-management-workshop-imi-ju-beneficiaries
[19] http://www.imi.europa.eu/events/2013/03/08/financial-management-workshop-imi-ju-beneficiaries
[20] http://www.imi.europa.eu/content/events